Yes, Mr Cartland it is inconvenient that you do not fact check. You wont, because it doesn't support yr narrative. So I did it for you! 1 in 271 approx rates.
kff.org/health-information-t…
fullfact.org/health/amish-au…
statnews.com/2025/10/02/amis…
7
135
A brilliant explanation of the terrible Brian Hooker paper.
Thanks to @jsm2334 👏
Replying to @BrianHookerPhD @CHDTVLive @ChildrensHD @CHD_TheDefender @maryhollandnyc @Paul__Rasmussen
This study has so many fundamental issues, it is difficult to even begin to explain them all. Here are some of the most important:
1. Highly selective and poorly explained study population. The authors select just 14,235 children from a Medicaid database containing more than 10 million patients, without adequately explaining the selection process or demonstrating that the selected children are representative. This raises serious concerns about selection bias. Their subsequent analyses restrict the sample even further, ultimately retaining only 35,410 of the original 156,585 child-years (22.6%) in the three well-child-visit strata used for their primary adjusted analysis, excluding over three-quarters of the original observations. These exclusions are based on healthcare utilization, potentially introducing additional selection bias.
2. Unreliable vaccination records and potentially serious misclassification bias. The study classifies 32% of children as completely unvaccinated, and only 38% have a recorded MMR vaccination. The authors themselves acknowledge that vaccinations received outside the Medicaid system would be missed, meaning many supposedly unvaccinated children may actually have been vaccinated. Critically, these same children may also have medical visits and chronic disease diagnoses that were never captured in Medicaid. Thus, children with incomplete records could appear both unvaccinated and unusually healthy, artificially creating an association between recorded vaccination and disease. The authors claim that missing vaccinations can only weaken the observed associations, but this is incorrect. When missing vaccination records are associated with missing diagnoses, the resulting bias could actually produce or exaggerate the very associations they interpret as evidence of vaccine harm.
3. Reverse causation and incorrect temporal ordering. Vaccinations and diagnoses occurring in the same year are analyzed together, even when the diagnosis occurred before the vaccination. For example, children with asthma or underlying respiratory problems are more likely to receive influenza vaccines, potentially explaining the reported association between influenza vaccination and asthma. Without establishing that vaccination preceded disease onset, the authors cannot reliably distinguish cause from consequence. They acknowledge this problem but do not resolve it.
4. Misleading and selectively presented dose-response relationships. The authors argue that increasing diagnoses with increasing vaccinations provides evidence of cumulative vaccine harm. But cumulative recorded vaccinations are also related to healthcare utilization, age, calendar time, and completeness of medical records, all of which could produce apparent dose-response patterns without any causal effect.
Additionally, several relationships are not consistently increasing as the authors suggest. For example, the autism rate is highest after just one recorded vaccination and generally lower at higher vaccination counts. Rather than acknowledging that this contradicts a cumulative dose-response interpretation, the authors speculate that susceptible children develop autism after their first vaccination and then stop vaccinating. In Figure 1A, they also construct an apparently increasing pattern using selectively combined hepatitis B and MMR vaccination categories, rather than presenting a straightforward dose-response relationship. Such selective grouping and post hoc explanations are not compelling evidence of causality.
5. Inappropriate statistical treatment of repeated observations and failure to account for correlation of records from the same child. The authors treat 156,585 child-years from just 14,235 children as separate observations, ignoring the substantial correlation among repeated observations from the same child. This inflates the apparent effective sample size and leads to artificially counting individual children multiple times as if they were indepednent observations, invalidating conventional uncertainty calculations. They acknowledge this problem but do not properly address it statistically.
6. Ad hoc and statistically unjustified adjustment procedure. The authors calculate Pearson correlations separately within strata defined by the number of well-child visits, then combine them using weights proportional to the square root of the number of observations in each stratum. This is not a standard method for estimating an adjusted association, the weighting scheme is not adequately justified, and the resulting quantity has no clear statistical or epidemiological interpretation. It is not equivalent to a properly adjusted regression coefficient or risk ratio.
7. Questionable outcome definitions. The analyses frequently treat diagnosis codes recorded in a particular year as disease incidence, even though many represent ongoing conditions diagnosed previously. Their measure of overall health, based on the number of recorded diagnoses, is also heavily influenced by healthcare utilization and coding practices rather than necessarily reflecting underlying disease burden.
8. Severe differences in healthcare utilization and diagnosis. Children with more recorded vaccinations are likely to have more contact with the healthcare system, giving them more opportunities to receive diagnoses of autism, ADHD, asthma, and other conditions. This alone could generate many of the reported associations, even if vaccines had no effect on disease risk.
9. Inadequate adjustment for differences in healthcare utilization. The authors attempt to address this by comparing children with the same number of annual well-child visits. But having the same number of preventive visits does not mean children have comparable numbers of sick visits, specialist evaluations, developmental assessments, or opportunities to receive diagnoses. Their claim that this eliminates differential diagnosis bias is unjustified. Furthermore, conditioning on healthcare utilization can itself introduce selection or collider bias.
10. Failure to adjust for major confounders. The analyses do not adequately account for differences in sex, birth year, socioeconomic circumstances, prematurity, birth weight, maternal health, underlying medical conditions, or other factors that could influence both vaccination and disease risk. They do not even present a baseline characteristics table demonstrating whether the groups are comparable.
11. Unsupported assumptions about the direction of bias. Beyond their incorrect claim about missing vaccination records, the authors argue that healthy-vaccinee bias should make vaccinated children appear healthier, so finding higher disease rates among them must be particularly persuasive. But different biases can operate in different directions. Confounding by indication, differential diagnosis, and incomplete records could all generate apparent harmful associations, and there is no justification for assuming that the net bias must favor vaccinated children, especially across a diverse set of measures.
12. No meaningful uncertainty estimates, measures of statistical significance, or sensitivity analyses. The authors provide no appropriate confidence intervals for their major risk comparisons and do not adequately examine how their results change under alternative assumptions about confounding, missing vaccinations, healthcare utilization, or selection bias. Some of their most dramatic autism claims come from a dataset containing only 152 autism cases, with no detailed case counts provided for the relevant exposure groups.
13. Lack of independent corroboration and conflict with stronger evidence, which BTW is not acknowledged. The authors interpret their findings as supporting substantial vaccine-associated harm without adequately reconciling them with much larger, better-controlled studies, including nationwide registry studies finding no increased autism risk after MMR vaccination. If vaccination caused effects as large as those suggested here, one would expect substantial corroborating evidence in other well-designed studies.
14. Conclusions FAR beyond what the data support. Despite acknowledging major limitations, the authors conclude that cumulative vaccination appears broadly damaging to children's health. Their analyses cannot distinguish vaccine effects from several plausible sources of bias, much less establish a harmful cumulative biological effect.
OK. I did get into many of the key flaws, but this is not an exhaustive list.
The fundamental problem is not simply that this is an observational study or that it cannot definitively prove causation. Well-designed observational studies can provide compelling causal evidence.
The problem is that this study fails to adequately address some of the most basic requirements of observational epidemiology: reliable exposure measurement, comparable groups, proper temporal ordering, control of confounding, and valid statistical analysis.
It is not a matter of it being an observational study with the usual limitations, it is a matter of the authors conducting a study with an enormous number of fundamental flaws and issues, many of which were not inherent, but directly caused by the design and modeling choices made by the authors.
The resulting associations they try to intepret as evidence of vaccine harm could easily arise from these biases even if vaccination had no harmful effect on the outcomes being studied. As a result, the reported associations provide little credible evidence for the causal conclusions the authors draw.
Mr Cartland. You know full well that this is not true. Information below in 2nd headline.
fullfact.org/health/tetanus-…
publichealthcollaborative.or…
4
83
🧵 Mr Cartland you share the abstract rather than the full research.👇
oncotarget.com/article/28824…
Some of the research states that CA diagnosis after 1st vaccination. NOT the Oncogenesis which clearly shows this would have been before having a vaccine.
1)
1
6
106
5) Studies included irrespective of patient age, sex, geographic region, cancer histology comorbs, socioeconomic deprivation and determinants of health outcomes. We know how unhealthy lifestyle can contribute to cancer. Smoking, drinking alcohol, poor diet. Etc.
1
27
6) Credit to the excellent @DrAdrianWong. 👏👏
nitter.gq/DrAdrianWong/status/21…
Anti-vaccine accounts keep recycling last year's 8.4M Korean study to claim COVID-19 vaccines cause cancer.
Now the VERY SAME journal has published a 36-million-person study over 50 months post-rollout—and found NO cancer surge.
Full breakdown below 👇
2
1
24
No Mr Cartland. If you had bothered to read the actual research, see the explanation of the limitations of the research and the actual research.
yahoo.com/news/articles/fact…
excli.de/excli/article/view/…
If anyone has any concerns please talk to your trusted healthcare professional.
2
12
352
Mr Cartland flanks A&P Cribriform plate is a thin,sieve like horizontal section of the ethmoid bone that forms the roof of the nasal cavity, part of the anterior cranial fossa floor. It supports the olfactory bulb lets olfactory nerve fibers pass from the nasal cavity to brain
2
10
230
Thoughts @MobyRichard666 ❤️💙
Crystal Palace eyeing potential January move for Ivan Toney talksport.com/football/47217…
2
3
244
Addendum the flu vaccine cannot be sprayed up that far and the PCR swab only reaches the back of the nasal passage or throat, far from the brain and protected by solid bone
1
7
29
Im hoping we see a return to the starting 11 ❤️💙
UEFA Conference League Player of the Season ✅
UEFA Conference League Golden Boot Winner ✅
A little reminder of what Ismaïla Sarr is capable of. 😒
#CPFC
2
86
The research you shared are animal studies and in vitro studies using pancreatic cancer cells and concentration of IVM.
Some of the research dates back to 2010-2018
Mr Cartland, oh this is embarrassing. You think the drug is Ivermectin? If you had bothered to read the trial you would know the drugs being developmented are:
Daraxonrasib, Zoldonrasib, ERAS-0015.
cancer.gov/types/pancreatic/…
General information:
pancreaticcancer.org.uk/info…

















